Centers for Disease Control and Prevention | mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-Cov-2 variants |
---|---|
Centers for Disease Control and Prevention | mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-Cov-2 variants |
Interim considerations for COVID-19 vaccination of healthcare personnel and long-term care facility residents.
14Vaccination considerations for persons with underlying medication conditions | Centers for Disease Control and Prevention |
---|---|
Pfizer-BioNTech vaccine: Fact sheet for recipients and caregivers | When vaccine is limited, who should get vaccinated first? Centers for Disease Control and Prevention |
Centers for Disease Control and Prevention.